Along with NT-proBNP, we also tested these biomarkers: monocyte chemoattractant protein-1 (MCP-1), involved in inflammation and atherothrombosis, among other processes [8,9]: galectin-3, related to malignancies, heart failure, thrombosis, and renal dysfunction [10,11]; high-sensitivity cardiac troponin I (hsTnI), which has been described to have prognostic value in stable CAD [12]; and vitamin D (calcidiol) plasma levels, as low levels of this molecule were related to cancer [13]. The gene discussed is NPPB; the disease is cancer.